Diabetes drug could sharpen scans for hidden heart disease
NCT ID NCT06510894
Summary
This study aims to see if adding a short course of an approved diabetes/heart failure drug (sotagliflozin) to a special low-carb diet helps get clearer pictures of heart inflammation on a PET scan. The goal is to improve the diagnosis of cardiac sarcoidosis, a condition where inflammation causes scarring in the heart. Researchers will give the drug and diet to 40 healthy volunteers and then perform a heart scan to measure how well the heart's sugar use is suppressed for a clearer image.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.